Published in Cancer on November 15, 2008
Costs and effectiveness of neonatal male circumcision. Arch Pediatr Adolesc Med (2012) 2.31
The Strong Protective Effect of Circumcision against Cancer of the Penis. Adv Urol (2011) 1.63
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer (2012) 1.63
Penile cancer: current therapy and future directions. Ann Oncol (2013) 1.54
Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health (2010) 1.53
Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study). Cancer Epidemiol Biomarkers Prev (2011) 1.37
Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J (2010) 1.22
Genital HPV infection and related lesions in men. Prev Med (2011) 1.19
Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals. J Infect Dis (2013) 1.17
Epidemiology and pathology of HPV disease in males. Gynecol Oncol (2010) 1.15
Reduced clearance of penile human papillomavirus infection in uncircumcised men. J Infect Dis (2010) 1.01
Penile cancer: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2013) 0.97
Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol (2011) 0.94
An opportunity for cancer prevention during preadolescence and adolescence: stopping human papillomavirus (HPV)-related cancer through HPV vaccination. J Adolesc Health (2012) 0.93
Ethnic and racial differences in HPV knowledge and vaccine intentions among men receiving HPV test results. Vaccine (2011) 0.93
Quality of life valuations of HPV-associated cancer health states by the general population. Sex Transm Infect (2012) 0.91
Human papillomavirus in men: an update. J Low Genit Tract Dis (2011) 0.84
Penile cancer disparities in Puerto Rican men as compared to the United States population. Int Braz J Urol (2013) 0.84
HPV Prevalence in Multiple Anatomical Sites among Men Who Have Sex with Men in Peru. PLoS One (2015) 0.81
Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancer. Clin Cancer Res (2014) 0.81
Penile preserving and reconstructive surgery in the management of penile cancer. Nat Rev Urol (2016) 0.79
Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programs. World J Urol (2014) 0.78
Current and future strategies in the diagnosis and management of penile cancer. Adv Urol (2011) 0.77
HPV Vaccine and Latino Immigrant Parents: If They Offer It, We Will Get It. J Immigr Minor Health (2016) 0.76
Attitudes surrounding implementation of the HPV vaccine for males among primary care providers serving large minority populations. J Health Care Poor Underserved (2013) 0.75
Vaccinate boys with the HPV vaccine? Really? J Spec Pediatr Nurs (2013) 0.75
Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study. PLoS One (2016) 0.75
CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma. Cancer Res (2016) 0.75
Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study. PLoS One (2016) 0.75
Evaluation of fotonovela to increase human papillomavirus vaccine knowledge, attitudes, and intentions in a low-income Hispanic community. BMC Res Notes (2015) 0.75
The utilization of oncology web-based resources in Spanish-speaking Internet users. Am J Clin Oncol (2012) 0.75
Hidden penile squamous cell carcinoma: A case report. Can Urol Assoc J (2014) 0.75
Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies? Clin Transl Imaging (2016) 0.75
Cancer Prevention: HPV Vaccination. Semin Oncol Nurs (2016) 0.75
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med (2002) 10.80
Chapter 2: The burden of HPV-related cancers. Vaccine (2006) 7.70
Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis (2006) 4.67
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst (2004) 3.11
History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92
Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis (2007) 2.86
Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer (2005) 2.79
Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis (2008) 2.58
Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol (2007) 2.23
Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect (2002) 2.05
Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer (2008) 2.00
Incidence trends in primary malignant penile cancer. Urol Oncol (2007) 1.90
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res (2001) 1.89
Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis (2004) 1.87
Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer (2006) 1.75
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol (2001) 1.67
Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control (2001) 1.65
Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol (2007) 1.53
Penile cancer. J Am Acad Dermatol (2006) 1.50
Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer (2006) 1.18
Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003. Cancer Epidemiol Biomarkers Prev (2007) 1.06
The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol (2006) 1.05
Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer (2001) 1.05
Risk factors for penile cancer: results from a case-control study in China. Int J Cancer (1991) 1.04
Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes. J Med Virol (2000) 1.03
Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer (2004) 0.99
Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix. Cancer Res (2007) 0.99
Clinicopathologic features and human papillomavirus dna prevalence of warty and squamous cell carcinoma of the penis. Am J Surg Pathol (2001) 0.97
Epidemiology of cancer of the testis and penis. Natl Cancer Inst Monogr (1979) 0.97
Clinical staging of cancer of the penis: by size? By localization? Or by depth of infiltration? Eur Urol (1990) 0.85
Advances in the treatment of carcinoma of the penis. Urology (2005) 0.79
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
The somatic genomic landscape of glioblastoma. Cell (2013) 11.73
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst (2006) 6.41
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Rapid-learning system for cancer care. J Clin Oncol (2010) 3.13
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol (2011) 3.11
Prevalence of colorectal cancer screening among adults--Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 2.70
Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck (2009) 2.59
Burden of cervical cancer in the United States, 1998-2003. Cancer (2008) 2.57
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol (2013) 2.48
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat (2007) 2.41
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control (2007) 2.36
Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev (2005) 2.11
Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis (2009) 2.10
Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control (2007) 2.09
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer (2008) 2.03
Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol (2002) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Cancer mortality surveillance--United States, 1990-2000. MMWR Surveill Summ (2004) 1.94
Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis (2008) 1.93
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92
Review and evaluation of methods correcting for population stratification with a focus on underlying statistical principles. Hum Hered (2008) 1.92
Cancer incidence trends among Asian American populations in the United States, 1990-2008. J Natl Cancer Inst (2013) 1.90
Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006. MMWR Surveill Summ (2010) 1.80
Development of a panel of genome-wide ancestry informative markers to study admixture throughout the Americas. PLoS Genet (2012) 1.74
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Information on ancestry from genetic markers. Genet Epidemiol (2004) 1.72
CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. Hum Pathol (2005) 1.72
Breast cancer screening among adult women--Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 1.72
Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One (2013) 1.71
Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev (2006) 1.65
Updating the natural history of human papillomavirus and anogenital cancers. Vaccine (2012) 1.65
Measuring dietary change in a diet intervention trial: comparing food frequency questionnaire and dietary recalls. Am J Epidemiol (2003) 1.65
Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control (2009) 1.65
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res (2011) 1.64
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer (2012) 1.63
Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.62
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol (2004) 1.62
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol (2013) 1.61
Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer (2007) 1.60
Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control (2008) 1.60
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59
Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans. Environ Health Perspect (2007) 1.56
Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. Proc Natl Acad Sci U S A (2009) 1.51
Anatomic distribution of malignant melanoma on the non-Hispanic black patient, 1998-2007. Arch Dermatol (2012) 1.49
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet (2010) 1.47
Descriptive epidemiology of colorectal cancer in the United States, 1998-2001. Cancer (2006) 1.46
Use of state cancer surveillance data to estimate the cancer burden in disaster-affected areas--Hurricane Katrina, 2005. Prehosp Disaster Med (2007) 1.44
EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer (2014) 1.44
Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001. Cancer (2006) 1.43
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer (2013) 1.42
Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol (2005) 1.42
Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet (2009) 1.42
GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev (2007) 1.42
Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol (2003) 1.42
Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1). BMC Cancer (2010) 1.41
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer (2014) 1.40
Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.37
Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol (2006) 1.37
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Health-related quality of life in cancer survivors between ages 20 and 64 years: population-based estimates from the Behavioral Risk Factor Surveillance System. Cancer (2008) 1.34
Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control (2009) 1.31
Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst (2012) 1.31
Colorectal cancer incidence and screening - United States, 2008 and 2010. MMWR Surveill Summ (2013) 1.31
Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2010) 1.30
Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer. Cancer Prev Res (Phila) (2013) 1.29
Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 1.26
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis (2012) 1.26
Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int J Cancer (2013) 1.25
Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006. J Am Acad Dermatol (2011) 1.20
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One (2011) 1.20
Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol (2011) 1.20
Trends and dietary determinants of overweight and obesity in a multiethnic population. Obesity (Silver Spring) (2006) 1.19
Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev (2009) 1.19
Variability of cervical cancer rates across 5 Appalachian states, 1998-2003. Cancer (2008) 1.19
Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int J Cancer (2010) 1.19
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer (2011) 1.17
Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer (2008) 1.17
Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prev Res (Phila) (2013) 1.17
Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol (2009) 1.17
Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.16
Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence. PLoS One (2012) 1.16
Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus. Obstet Gynecol (2003) 1.15
Cancer incidence trends among native Hawaiians and other Pacific Islanders in the United States, 1990-2008. J Natl Cancer Inst (2013) 1.14
A segregation analysis of Barrett's esophagus and associated adenocarcinomas. Cancer Epidemiol Biomarkers Prev (2010) 1.13
Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer (2008) 1.12